Dynavax (DVAX) 'Buy' Maintained at Jefferies Post Q4

March 11, 2014 7:55 AM

Jefferies analyst Thomas Wei reiterated a Buy rating and $3 price target on Dynavax Technologies (NASDAQ: DVAX) following Q4 results.

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found